Assessing the Development of Artificial Intelligence Technologies In Radiation Therapy and Targeting Irregular Masses

Eric Bear, Jessica Singh, and Michael Wahrman   ABSTRACT The purpose of this paper is to evaluate the use of artificial intelligence in the medical use of particle accelerators for both treatment (radiation therapy) and imaging. We will first discuss the implications of artificial intelligence (AI) on particle accelerators, starting with basic control mechanisms and then moving to complex systems such as neural networking. AI has the potential to increase efficiency and precision in all […]

A New Signaling Pathway in Diamond Blackfan Anemia

Sriya Kudaravalli Diamond Blackfan Anemia (DBA) is blood disease in which the bone marrow malfunctions and fails to make enough erythrocytes, or red blood cells. Inherited in an autosomal dominant pattern, DBA affects approximately five to seven million infants globally, and about half of the DBA patients possess physical abnormalities, such as microcephaly, hypertelorism, Ptosis, micrognathia, webbed neck, absent thumbs, cataracts, and glaucoma. In addition, affected patients have an increased risk of developing acute myeloid […]

Innovative New Technology Attempting to Reduce Hospital Associated Infections

Kenneth Trang Introduction Today, the modern American is more likely than ever before to visit a hospital, local doctor, or any healthcare provider. In fact, 83% of Americans (268 million) visited a healthcare professional in 2015 ((Summary Health Statistics: National Health Interview Survey. Centers for Disease Control and Prevention. 2015)). However, while hospitals do have general health benefits, visiting one exposes patients to a new risk: healthcare associated infections (HAIs), also known as nosocomial infections. […]

The Retrospective Overview on Bioengineering Application of Induced Pluripotent Stem Cell

Min Jae Kim Keywords: iPS Cell, ES cell, Regenerative Medicine, Bioengineering, Organ Transplant, Stem Cell, Yamanaka Shinya, disease model Abstract The creation of the first Induced-Pluripotent Stem cell (iPS cell) from mice fibroblast cells in 2006 was promising. Subsequently in 2007, attempt to induce adult human fibroblasts into IPS cell was successful (Takahashi et al., 2007), thus opening its universal application into regenerative medicine. From this innovation, the continuous studies have allowed the iPS cell […]